FDA warned Houston seafood importer AF Import & Wholesale for missing written verification that its imported fish was processed safely.
What happened
FDA inspected the company's seafood importer establishment in Houston, TX on April 29-30, 2026, and had also inspected it on August 28-29, 2019. The agency found the firm had no written verification procedures, product specifications, or affirmative step (the documented action an importer must take to confirm foreign processors meet U.S. seafood HACCP rules), and no evidence that the fish it imported was processed under compliant conditions. FDA called the missing verification procedures a repeat observation from the 2019 inspection.
What FDA found
The company did not have or did not carry out written verification procedures, product specifications, and an affirmative step to ensure its imported fish was processed in line with the seafood HACCP rule.
21 CFR 123.12(a)(2)(ii)The company gave no evidence that the fish it imported was processed under conditions that meet the seafood HACCP regulation.
21 CFR 123.12(d)Because of these gaps, the imported fish is considered adulterated, meaning it was held under conditions where it may have been made harmful to health.
Section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. ยง 342(a)(4)
What FDA wants
FDA tells the company to respond in writing within 15 working days describing the specific corrections and including HACCP and importer verification records and evidence of its affirmative steps. If corrections are not complete, the company must explain the delay and say when they will be finished.
Who should pay attention
- U.S. buyers and distributors of imported seafood
- seafood importers and brokers using the same foreign suppliers
- retailers and restaurant chains sourcing imported fish
This is a summary. Read the original letter on fda.gov.